マルチセンターの臨床試験

Same author

In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat.

Naunyn-Schmiedeberg's archives of pharmacology·1996

Same author

Pharmacology of ingestive behaviour.

Therapie·1996

Same author

DNA topoisomerase inhibitors.

Cancer chemotherapy and biological response modifiers·1996

Same author

Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primates.

Xenobiotica; the fate of foreign compounds in biological systems·1995

Same author

Biological actions of drugs affecting serotonin and eating.

Obesity research·1995

Same author

Cultural shift in Italy's drug policy.

Lancet (London, England)·1995

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

関連する実験動画

マルチセンターの臨床試験

関連する概念動画

In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat.

Pharmacology of ingestive behaviour.

DNA topoisomerase inhibitors.

Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primates.

Biological actions of drugs affecting serotonin and eating.

Cultural shift in Italy's drug policy.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

マルチセンターの臨床試験

関連する概念動画

関連記事

In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat.

Pharmacology of ingestive behaviour.

DNA topoisomerase inhibitors.

Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primates.

Biological actions of drugs affecting serotonin and eating.

Cultural shift in Italy's drug policy.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.